Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004675. doi: 10.1161/CIRCOUTCOMES.118.004675

Table 2.

Patient characteristics by site video consent capability

Video consent
approved
(n = 3485 patients;
60 sites)
Video consent not
approved
(n = 4419
patients; 80 sites)
P- value
Demographics
  Age 68 (60, 75) 67 (59, 74) < 0.001
    Age ≥ 75 years old 959 (27.5%) 1041 (23.6%) < 0.001
  Female gender 1809 (51.9%) 2348 (53.1%) 0.26
  Race < 0.001
    White 2868 (82.3%) 3793 (85.8%)
    African American 537 (15.4%) 534 (12.1%)
    Asian 66 (1.9%) 84 (1.9%)
    American Indian/Alaskan 7 (0.2%) 4 (0.1%)
  Insurance < 0.001
    Private 2113 (60.6%) 2458 (55.6%)
    Government 1277 (36.6%) 1850 (41.9%)
    Other 3 (0.1%) 0 (0.0%)
    None 71 (2.0%) 108 (2.4%)
  College graduate or higher 1069 (30.7%) 1573 (35.6%) <0.001
Clinical Characteristics
  Atherosclerotic vascular disease 1450 (41.6%) 1977 (44.7%) 0.005
    Coronary artery disease 1206 (34.6%) 1624 (36.8%) 0.05
    Peripheral vascular disease 284 (8.2%) 419 (13.4%) 0.04
    Cerebrovascular disease 437 (12.5%) 593 (13.4%) 0.25
    History of MI 342 (9.8%) 666 (15.1%) < 0.001
  Diabetes 1216 (34.9%) 1847 (41.8%) < 0.001
  Hypertension 2679 (76.9%) 3446 (78.0%) 0.25
  Current/recent smoker 463 (13.3%) 597 (13.5%) 0.77
  Chronic kidney disease 360 (10.3%) 393 (8.9%) 0.03
  Currently taking statin 2399 (68.8%) 3253 (73.6%) < 0.001
  Core lab LDL-C level 99 (77, 126) 94 (73, 120) <0.001

Continuous variables expressed as median (25th, 75th percentile); categorical variables expressed as number (%).